echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Bone healing stem cells provide a "free ride" for cancer cells?

    Bone healing stem cells provide a "free ride" for cancer cells?

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    New research may help explain why long-dormant cancer cells suddenly become more aggressive
    .
    Soon after the primary tumor forms, cancer cells enter the bloodstream and invade bones and other tissues
    .
    In bones, these diffuse tumor cells (DTCs) hide in a niche around blood vessels, where they can remain dormant for a long time before unexplained awakening, ready to colonize
    surrounding tissues.
    Colonization — the final step in bone metastasis — typically occurs years after removal of the primary tumor, and its effects are estimated to kill hundreds of thousands of people in the United States each year
    .

    "If the cancer is already in the bone, what triggers it to grow back?" Cancer researchers at Baylor College of Medicine are trying to answer that question
    .

    Case studies have shown that bone metastases occur after dental implant surgery, and epidemiological studies have shown an increased risk of bone metastases after experiencing fractures, leading researchers to assume that the bone remodeling process after injury may initiate cancer cell division
    .
    In a study published October 26 in Cancer Discovery, Xiang H.
    -F.
    Zhang and his colleagues found that after fractures, DTCs in mice bind to perivascular stem cells, which the body sends to the site of injury to begin the healing process
    .
    Once they reach the fracture site, the cancer cells appear to proliferate along with bone remodeling, in which damaged bone is absorbed and new bone forms
    in its place.

    "This is a very important study because it validates clinical data that suggests that increased bone resorption promotes the growth of tumors in the bone, and it provides a mechanism by which this happens," said Theresa A.
    , a cancer researcher at the University of Texas MD Anderson Cancer Center who studies the mechanisms of bone metastasis.
    Guise wrote in an email that she was not involved in the effort
    .
    "These results advance our understanding of bone metastases and point to possible reasons why
    patients with bone metastases perform poorly when fractured.
    "

    Xiang H.
    -F.
    Zhang's early research showed that bone metastases tend to occur in osteogenic niches, the areas where
    osteoblasts and their cellular precursors live.
    The discovery prompted him and his colleagues to delve deeper into why bone remodeling exacerbates the spread
    of cancer cells.
    To confirm this effect, they focused on when bone remodeling was most active: after a
    fracture.
    The team implanted murine-derived tumors with bioluminescent genes into
    mice.
    After about 17 days, the researchers removed the tumor and broke the femurs
    of some of the animals.
    About 17 days after allowing bone remodeling to occur, biofluorescence imaging showed that the cancer cells had spread widely in the fractured femur and almost no cancer cells in
    the uninjured bone.

    The researchers then explored mechanisms that could explain this result
    by repeating the bioluminescence imaging experiment in mice with depleted bone cell types.
    Mice with reduced levels of NG2+ cells (a type of stem cell that can differentiate into osteoblasts) showed fewer bone metastases from fractures than mice with normal levels of NG2+ cells, suggesting that NG2+ cells played a role
    in transporting cancer cells to the fracture site.
    NG2+ cells, which reside in the space around blood vessels like DTCs, appear to migrate to osteogenic niches, Zhang said, and his experiments show that "the normal function of these cells is to promote bone remodeling
    .
    " "Spatial analysis of bone metastatic tissue revealed that NG2+ cells and DTCs were adjacent and often overlapping, providing further evidence for a link between the two cell types that could explain the link between
    bone remodeling and tumor growth.
    "

    Zhang said it would be nearly impossible to capture the real-time migration of the two types of cells in animals with current techniques, but in vitro experiments have shown that NG2+ and cancer cells have the ability to adhere to each other and move
    together.
    "So, the two cell types can definitely work together," he said, adding that two forms of an adhesion molecule called cadherin are the glue
    between them.

    The form of adhesion molecules expressed by stem cells is called N-cadherin, while the type of adhesion molecule produced by cancer cells is called E-cadherin
    .

    To find out whether the process they observed in mice might also apply to humans, Zhang and colleagues analyzed protein expression in samples of surgically removed early-stage human bone metastases caused by different types of cancer, including breast, prostate, colon and lung cancers
    .
    The researchers found NG2+ and N-cadherin in cells near cancer cells, suggesting that bone remodeling may affect metastasis regardless of the original cancer cell type, though Zhang said the researchers haven't looked at
    this in detail.

    "The technology used here is state-of-the-art and the data is comprehensive," Guise said, "and the icing on the cake is that the authors validated their experimental findings on bone metastasis in humans, which further strengthens this research
    .
    " ”

    In further experiments, NG2+ stem cell-depleted mice had fewer bone colonizations of DTCs even in the absence of fractures, suggesting that even the ongoing homeostasis bone remodeling may exacerbate bone metastasis
    .
    Zhang said that means people who experience faster bone remodeling, such as those with osteoporosis, may be at higher risk of
    metastasis.
    Guise agrees with this assessment, but notes that osteoporosis in older adults is not always associated
    with faster bone resorption.

    Zhang said it is possible to prevent bone metastasis
    by attacking the binding between N-cadherin and E-cadherin molecules expressed by cancer cells.
    However, the researchers found that eliminating N-cadherin slowed the rate of bone remodeling in
    mice.
    Preventing bone metastasis by hindering bone healing is not a viable approach, he said, so he and his colleagues will focus on attacking E-cadherin
    in future studies.

    While Guise says Zhang's proposed treatment is promising, she notes that "treatment must only target bone, as the loss of E-cadherin may promote malignancy in non-bone sites
    .
    " She explained that mutations in the gene that normally encode E-cadherin have been linked to
    breast and stomach cancer in humans.

    Blocking the connections between cadherin molecules may be more than just preventing bone metastasis, Zhang said, because as tumors grow, DTCs can metastasize from bone to other organs, where they may metastasize
    again.
    "We do think that if we can break that link, we can reduce not only the risk of bone metastasis, but also further metastasis to other organs
    .
    "


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.